InvestorsHub Logo
Followers 20
Posts 1059
Boards Moderated 0
Alias Born 04/01/2013

Re: attm post# 9445

Thursday, 06/27/2013 5:37:50 PM

Thursday, June 27, 2013 5:37:50 PM

Post# of 426316
Pfizer is just re-upping the previous 10 billion buyback from Dec 2011, there net income per year is more than that and the 10 billion based on the last 10 billion will be spread over at least the next 2 years, they still have more than that in net income per year, a large cash hoard balance sheet.

Since they did the same thing for the exact same amount in Dec 2011 I don't now how it relates to AMRN, if anything it's surprising the amount was the same with the Zoetis spin off being accretive to 2014 earnings they could have bumped the buyback to 11 or 12 billion.

This has zero effect on AMRN, if anything a mild positive because they did not increase the share repurchase amount from last time meaning they are keeping more cash on hand than they need to.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News